Landos Biopharma Inc

NASDAQ:LABP   3:59:51 PM EDT
6.39
-0.30 (-4.48%)
Earnings Announcements

Landos Biopharma Reports Q3 Loss Per Share $0.32

Published: 11/15/2021 12:46 GMT
Landos Biopharma Inc (LABP) - Landos Biopharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Landos Biopharma Inc- Qtrly Loss per Share $0.32.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.35

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.